Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127250851 | 12725085 | 1 | I | 201608 | 20160831 | 20160908 | 20160908 | EXP | PHHY2016FR121233 | NOVARTIS | 78.00 | YR | M | Y | 0.00000 | 20160908 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127250851 | 12725085 | 1 | PS | TASIGNA | NILOTINIB | 1 | Unknown | 02 DF, QD | 22068 | 2 | DF | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127250851 | 12725085 | 1 | Chronic myeloid leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127250851 | 12725085 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127250851 | 12725085 | Abdominal pain | |
| 127250851 | 12725085 | Gastrointestinal carcinoma | |
| 127250851 | 12725085 | General physical condition abnormal | |
| 127250851 | 12725085 | Metastasis | |
| 127250851 | 12725085 | Second primary malignancy | |
| 127250851 | 12725085 | Wound |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |